COMMUNIQUÉS West-GlobeNewswire

Genedrive PLC: Update on Distribution arrangements for India / SAARC
02/11/2017
2 November 2017 genedrive plc ("genedrive" or the "Company") Update on Distribution arrangements for India / SAARC [1] genedrive plc (LSE:GDR), the molecular diagnostics company, today provides an update on its [...]
NuCana plc to Present at the Jefferies 2017 London Healthcare Conference
02/11/2017
EDINBURGH, United Kingdom, Nov. 02, 2017 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq:NCNA), a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for cancer patients by applying its [...]
AC Immune SA to Receive Milestone Payment for Anti-Tau Antibody Moving into Phase 2 Trial for Alzheimer's Disease
02/11/2017
AC Immune to receive third milestone payment of CHF 14 million under collaboration agreement with Genentech Phase 2 to evaluate effects of anti-Tau antibody in people with prodromal-to-mild Alzheimer's disease Phase 1 [...]
Affimed to Present at the 26th Annual Credit Suisse Healthcare Conference
02/11/2017
Heidelberg, Germany, November 2, 2017 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. Adi [...]
Navamedic ASA: Invitation to presentation of third quarter results 2017
02/11/2017
Navamedic ASA invites you to a presentation of the third quarter 2017 figures. The presentation takes place at Hotel Continental, Stortingsgaten 24/26, 0117 Oslo, Friday 10 November. The presentation will start at 08.00 [...]
Navamedic ASA: Invitation to presentation of third quarter results 2017
02/11/2017
Navamedic ASA invites you to follow an online presentation of the third quarter 2017 figures. The presentation will be webcasted at www.navamedic.com - investor relations - presentations - webcast on Friday 10.11 2017 [...]
Photocure ASA:U.S. CMS improves reimbursement for Blue Light Cystoscopy with Cysview®
02/11/2017
Oslo, Norway, November 2,2017: Photocure ASA (OSE: PHO), announced today that the United States Centers for Medicare & Medicaid Services (CMS) has issued a Final Rule stating that it will reimburse hospital [...]
Notice to Attend the Extraordinary General Meeting of Immunicum
02/11/2017
Press Release 2 November 2017 Notice to Attend the Extraordinary General Meeting of Immunicum The shareholders of Immunicum AB (publ) (the "Company"), reg. no 556629-1786, are hereby invited to an Extraordinary General [...]
Zealand reports royalty revenue for the third quarter of 2017
02/11/2017
Company announcement - No. 49/2017 Zealand reports royalty revenue for the third quarter of 2017 Zealand reports royalty revenue of DKK 10.3 million/USD 1.6 million for Q3 2017 The revenue is based on total net sales of [...]
Galapagos moving forward in CF programs at NACFC 2017
02/11/2017
Ten posters and four oral presentations reflect progress toward triple combination therapy Mechelen, Belgium; 2 November 2017; 7.30 CET - At the North American Cystic Fibrosis Conference (NACFC) 2017, Galapagos NV ( [...]
The Board of Directors of Immunicum AB (publ) Resolves on a 90% Secured Rights Issue of up to SEK 223 Million to Finance Further Development of its Portfolio
02/11/2017
THIS PRESS RELEASE MAY NOT BE DISTRIBUTED OR RELEASED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR [...]
Sanofi : Q3 2017 Business EPS up 1.1% at CER FY 2017 Guidance Confirmed
02/11/2017
Paris, November 2, 2017 Q3 2017 Business EPS (1) up 1.1% at CER (2) FY 2017 Guidance Confirmed Q3 2017 Change Change at CER Change at CER/CS (3) 9M 2017 Change Change at CER Change at CER/CS (3) IFRS net sales reported [...]
Sanofi : Hausse de 1,1% du BNPA des activités à TCC au T3 2017 Perspectives 2017 confirmées
02/11/2017
Paris, le 2 novembre 2017 Hausse de 1,1% du BNPA des activités (1) à TCC (2) au T3 2017 Perspectives 2017 confirmées T3 2017 Var Var. (TCC) Var. à TCC/PC (3) 9M 2017 Var Var. (TCC) Var. à TCC/PC (3) Chiffre d'affaires [...]
Basilea reports on commercial progress of antifungal Cresemba® in Europe
02/11/2017
Cresemba launched by Pfizer in Spain and is now commercially available in all Top-5 EU markets Marketing authorization received for Switzerland Basel, Switzerland, November 2, 2017 - Basilea Pharmaceutica Ltd. (SIX: [...]
argenx to host KOL breakfast symposium on pemphigus vulgaris on November 10, 2017
02/11/2017
November 2, 2 017 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]
MDxHealth Nine Month Trading Update
02/11/2017
Patient test volume for the first nine months up 43% SelectMDx test volume in Europe increased nearly 400% NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CET, November [...]
Rapport d'activités des neuf premiers mois de MDxHealth
02/11/2017
Le volume des tests pour les patients a augmenté de 43 % les neuf premiers mois Le volume des tests SelectMDx en Europe a augmenté de près de 400 % COMMUNIQUÉ DE PRESSE / INFORMATION RÉGLEMENTÉE / INFORMATION [...]
TiGenix strengthens European IP protection around lead development program Cx601
02/11/2017
PRESS RELEASE TiGenix strengthens European IP protection around lead development program Cx601 Leuven (BELGIUM) - November 2, 2017, 07:00h CET - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced [...]
TiGenix renforce la protection intellectuelle en Europe pour le programme de développement du Cx601
02/11/2017
COMMUNIQUÉ DE PRESSE TiGenix renforce la protection intellectuelle en Europe pour le programme de développement du Cx601 Louvain (BELGIQUE) - 2 novembre 2017, 07h. CET - TiGenix NV (Euronext Brussels et NASDAQ : TIG), [...]

Pages